Zepnap 2mg Tablet contains Lorazepam, a benzodiazepine class medication primarily indicated for the management of anxiety disorders, short-term relief of symptoms of anxiety, and as a sedative or hypnotic agent. Lorazepam exerts its therapeutic effects by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, resulting in anxiolytic, anticonvulsant, muscle relaxant, and sedative properties. Zepnap is commonly prescribed for patients experiencing acute anxiety episodes, insomnia related to anxiety or transient stress, and as premedication before surgical or diagnostic procedures to induce sedation and amnesia. The standard dosage of Zepnap 2mg Tablet should be individualized based on patient response, age, and clinical condition, with caution advised in elderly patients and those with hepatic or renal impairment. Due to its potential for dependence, tolerance, and withdrawal symptoms, Zepnap should be used at the lowest effective dose for the shortest duration necessary. Common adverse effects include drowsiness, dizziness, and impaired coordination, and patients should avoid alcohol and activities requiring mental alertness while under treatment. Zepnap is contraindicated in individuals with hypersensitivity to benzodiazepines, severe respiratory insufficiency, and acute narrow-angle glaucoma. Proper medical supervision is essential to ensure safe and effective use.